The Conversation (0)
Eve announced its subsidiary Natural MedCo obtain an amendment to its Canadian production license to include bottled cannabis oil development.
Eve (TSXV:EVE) announced its subsidiary Natural MedCo obtain an amendment to its Canadian production license to include bottled cannabis oil development.
As quoted in the press release:
“We are pleased to announce that we have been granted a license to produce extracts,” said CEO, Melinda Rombouts. “We are currently expanding our greenhouse from 220,000 [square feet] to 1,000,000 [square feet] to meet the expected demand from the consumer market. As one of Canada’s largest producers of dried flower, we believe we can become a leading supplier in the extracts market as well. This license furthers our ability to produce and market a wide array of products focused on addressing women’s needs under our recreational brand Eve.”
The amended license authorizes the production of bottled cannabis oil. Shipping would commence after Health Canada provides authorization to sell cannabis oil.
Click here to read the full press release.
Source: globenewswire.com
